ArticleAmerican journal of ophthalmology case reports2025
Management of neurotrophic corneal ulcer with a topical liposomal ozonated oil: A report on three clinical cases.
Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Real-World Management and Patterns of Antibiotic Use in Patients with Keratitis and Ocular Surface Injuries: A Nationwide Survey Study in Spain.Antibiotics (Basel, Switzerland) · 2026Article
- Exploratory Pilot Study on the Tolerability and Ocular Surface Effects of Liposomal Ozonated Oil Compared with Standard Prophylaxis in Cataract Surgery. The CAREST Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To present three cases of neurotrophic corneal ulcer successfully treated with topical liposomal ozonated oil (Ozonest®) eye drops and to assess its potential usefulness in preventing corneal infection and promoting epithelialization. Observations: Neurotrophic corneal ulcers require appropriate therapy that includes re-epithelialization and prevention of infection usually with antibiotic therapy. The emergence of multidrug-resistant bacterial strains due to the overuse of antibiotics in the treatment of infectious diseases has prompted researchers to investigate new antimicrobial formulations. Liposomal ozonated oil has demonstrated antiseptic (antibacterial, antifungal and antiviral) and tissue repair properties, making it a promising candidate for the prevention and treatment of acute and chronic local infections. Additionally, its specific formulation ensures good tolerability and biocompatibility with the ocular surface. In the three cases of neurotrophic ulcer presented here, topical liposomal ozonated oil (Ozonest®) was used, resulting in good resolution and complete re-epithelialization without superinfection. Conclusions and importance: The use of topical liposomal ozonated oil (Ozonest®) may have an antiseptic role and help in the closure of neurotrophic ulcers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.